CoChat

Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function

Open access
Hu, Lili, Wang, Bingjie, Zhang, Yan · 2017 · Alzheimer's Research & Therapy

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Serotonin receptor 5-HT6 is involved in cognition and Alzheimer's disease (AD) development. However, the mechanism of 5-HT6 in AD pathology is not clear. METHODS: Since 5-HT6 is almost exclusively expressed in the primary cilia, using immunostaining we examined the number of cilia in the hippocampus of AD animal model APP/PS1 mice. By overexpressing and knocking down 5-HT6 in the primary cultured hippocampal neurons, we investigated the roles of 5-HT6 in alternating ciliary morphology. Furthermore, 5-HT6 antagonist was applied to confirm its roles in cognition using the Morris water maze test, Y maze, and fear conditioning. RESULTS: In the present study, we found that the primary cilia were elongated in the hippocampus of APP/PS1 mice compared with WT mice. 5-HT6 regulated cilia length, influenced cilia and axon initial segment (AIS) morphology, and affected localization of ARL13B and AnkG. We also found that, by changing cilia morphology, the AIS was elongated, branched, and more proximal to the cell body in both WT and APP/PS1 mouse neurons. Alterations of cilia also decreased the axonal length in WT and APP/PS1 neurons. Furthermore, in the water maze test, Y maze, and fear conditioning test, 5-HT6 antagonist SB271046 recovered the cognitive impairment of APP/PS1 mice. CONCLUSION: We suggest that 5-HT6 plays a critical role in AD development through regulating the morphology and function of neuronal primary cilia, which is possibly related to the AIS and axon alterations in AD development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13195-017-0304-4

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 5-HT6 regulated the length of primary cilia in APP/PS1 mice. (a) Overexpression of 5-HT6 induced elongation and branched primary cilia in hippocampal neurons. 5-HT6 (green) and ARL13B (purple) indicated primary cilia. DAPI indicated nuclei. (b) Overexpression of 5-HT6 increased the length and branching numbers of primary cilia. Cilia length, **p < 0.01 (t test); number of branches, **p < 0.01 (Mann–Whitney U test). (c) Knocking down 5-HT6 decreased the length of primary cilia in hippocampal neurons. (d) Length of primary cilia was reduced by siRNA against 5-HT6. Cilia length, **p < 0.01 (Mann–Whitney U test). The branching number of primary cilia was unchanged (remaining at 1) after exposure to siRNA against 5-HT6. Number of branches, p = 0.62 (t test). (e) Primary cilia elongated gradually with increasing 5-HT6 transfection. 5-HT6 (green) indicated primary cilia. (f) Cilia length increased with upregulated 5-HT6. All groups were compared with the control group, which was transfected with no vectors. 0.5 μg, ***p < 0.001; 1 μg, ***p < 0.001; 2 μg, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). (g) Primary cilia length increased as the 5-HT concentration increased. 5-HT6 (green) and ARL13B (red) were markers of primary cilia. MAP2 (purple) served as a neuronal marker. (h) Ciliary length was elongated by 5-HT in a gradual and concentration-dependent manner. All groups were compared with the control group to which was applied 0 nM 5-HT. 2 nM, **p < 0.01; 200 nM, ***p < 0.001 (one-way ANOVA, F 2,121 = 220.6, p < 0.001). (i) siRNA against 5-HT6 decreased the primary ciliary length of hippocampal neurons in APP/PS1 mice. AC3 (red) indicated primary cilia. (j) Knocking down 5-HT6 reduced the ciliary length of hippocampal neuron in APP/PS1 and WT mice. All groups were compared with the group exposed to scrambled siRNA. siRNA versus Scramble in WT, *p < 0.05; siRNA versus Scramble in APP/PS1, **p < 0.01 (two-way ANOVA: interaction, F 1,195 = 224.8, p < 0.001; treatment, F 1,195 = 417.6, p < 0.001; gene, F 1,195 = 389.6, p < 0.001). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent protein
Fig. 1 5-HT6 regulated the length of primary cilia in APP/PS1 mice. (a) Overexpression of 5-HT6 induced elongation and branched primary cilia in hippocampal neurons. 5-HT6 (green) and ARL13B (purple) indicated primary cilia. DAPI indicated nuclei. (b) Overexpression of 5-HT6 increased the length and branching numbers of primary cilia. Cilia length, **p < 0.01 (t test); number of branches, **p < 0.01 (Mann–Whitney U test). (c) Knocking down 5-HT6 decreased the length of primary cilia in hippocampal neurons. (d) Length of primary cilia was reduced by siRNA against 5-HT6. Cilia length, **p < 0.01 (Mann–Whitney U test). The branching number of primary cilia was unchanged (remaining at 1) after exposure to siRNA against 5-HT6. Number of branches, p = 0.62 (t test). (e) Primary cilia elongated gradually with increasing 5-HT6 transfection. 5-HT6 (green) indicated primary cilia. (f) Cilia length increased with upregulated 5-HT6. All groups were compared with the control group, which was transfected with no vectors. 0.5 μg, ***p < 0.001; 1 μg, ***p < 0.001; 2 μg, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). (g) Primary cilia length increased as the 5-HT concentration increased. 5-HT6 (green) and ARL13B (red) were markers of primary cilia. MAP2 (purple) served as a neuronal marker. (h) Ciliary length was elongated by 5-HT in a gradual and concentration-dependent manner. All groups were compared with the control group to which was applied 0 nM 5-HT. 2 nM, **p < 0.01; 200 nM, ***p < 0.001 (one-way ANOVA, F 2,121 = 220.6, p < 0.001). (i) siRNA against 5-HT6 decreased the primary ciliary length of hippocampal neurons in APP/PS1 mice. AC3 (red) indicated primary cilia. (j) Knocking down 5-HT6 reduced the ciliary length of hippocampal neuron in APP/PS1 and WT mice. All groups were compared with the group exposed to scrambled siRNA. siRNA versus Scramble in WT, *p < 0.05; siRNA versus Scramble in APP/PS1, **p < 0.01 (two-way ANOVA: interaction, F 1,195 = 224.8, p < 0.001; treatment, F 1,195 = 417.6, p < 0.001; gene, F 1,195 = 389.6, p < 0.001). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent proteinCC BY · PubMed Central
Fig. 2 Elongated primary cilia and upregulated 5-HT6 in the hippocampus of APP/PS1 mice. (a) Primary cilia marker AC3 (green) indicated the primary cilia in brain sections from APP/PS1 and WT C57 mice by immunofluorescence staining in vivo. DAPI (blue) was used to indicate cell nuclei. Scale bars, 500 μm. (b) Primary cilia were elongated in the hippocampus of APP/PS1 mice. Scale bars, 10 μm. (c) Primary cilia of the hippocampus were obviously elongated in the hippocampus of APP/PS1 mice. Cilia length, **p < 0.01 (t test). The number of primary cilia (normalized to the number of cell nuclei) was similar in the hippocampus of APP/PS1 and WT mice. Number of cilia, p = 0.76 (Mann–Whitney U test). (d) Primary cultures of hippocampal neurons showed that the length of primary cilia was increased by immunostaining in vitro. ARL13B (red) and 5-HT6 (purple) indicated primary cilia. MAP2 (green) was used as a neuronal marker. DAPI (blue) indicated cell nuclei. (e) Primary cilia were elongated in primary cultures of hippocampal neurons from APP/PS1 and WT mice. Cilia length, **p < 0.01 (t test). (f) Protein levels of 5-HT6 and GAPDH in the hippocampus, PFC, olfactory blub, striatum, diencephalon, cerebellum, and whole brain of APP/PS1 and WT mice. GAPDH was used as an internal control. (g) In APP/PS1 mice, the protein level of 5-HT6 (normalized to GAPDH) was significantly increased in the hippocampus. Hippocampus, *p < 0.05; PFC, *p < 0.05; olfactory blub, p = 0.62; striatum, p = 0.22; diencephalon, p = 0.57; cerebellum, p = 0.71; whole brain, p = 0.13 (Mann–Whitney U test). All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole
Fig. 2 Elongated primary cilia and upregulated 5-HT6 in the hippocampus of APP/PS1 mice. (a) Primary cilia marker AC3 (green) indicated the primary cilia in brain sections from APP/PS1 and WT C57 mice by immunofluorescence staining in vivo. DAPI (blue) was used to indicate cell nuclei. Scale bars, 500 μm. (b) Primary cilia were elongated in the hippocampus of APP/PS1 mice. Scale bars, 10 μm. (c) Primary cilia of the hippocampus were obviously elongated in the hippocampus of APP/PS1 mice. Cilia length, **p < 0.01 (t test). The number of primary cilia (normalized to the number of cell nuclei) was similar in the hippocampus of APP/PS1 and WT mice. Number of cilia, p = 0.76 (Mann–Whitney U test). (d) Primary cultures of hippocampal neurons showed that the length of primary cilia was increased by immunostaining in vitro. ARL13B (red) and 5-HT6 (purple) indicated primary cilia. MAP2 (green) was used as a neuronal marker. DAPI (blue) indicated cell nuclei. (e) Primary cilia were elongated in primary cultures of hippocampal neurons from APP/PS1 and WT mice. Cilia length, **p < 0.01 (t test). (f) Protein levels of 5-HT6 and GAPDH in the hippocampus, PFC, olfactory blub, striatum, diencephalon, cerebellum, and whole brain of APP/PS1 and WT mice. GAPDH was used as an internal control. (g) In APP/PS1 mice, the protein level of 5-HT6 (normalized to GAPDH) was significantly increased in the hippocampus. Hippocampus, *p < 0.05; PFC, *p < 0.05; olfactory blub, p = 0.62; striatum, p = 0.22; diencephalon, p = 0.57; cerebellum, p = 0.71; whole brain, p = 0.13 (Mann–Whitney U test). All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindoleCC BY · PubMed Central
Fig. 3 5-HT6 mutations regulated ciliary length, cilia branching number, and percentage of neurons with branched cilia. (a) D72A, D106A, and F69L + T70I + D72A mutations influenced ciliary length. These mutations of 5-HT6 restored primary ciliary length increased by overexpression of 5-HT6. 5-HT6 (green) indicated primary cilia. (b) D72A, D106A, and F69L + T70I + D72A mutations restored normal cilia length. EGFP, ***p < 0.001; D72A, **p < 0.01; D106A, **p < 0.01; F69L + T70I + D72A, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). (c) D72A, D106A, and F69L + T70I + D72A mutations influenced the number of ciliary branches. These mutations of 5-HT6 significantly reduced the number of ciliary branches. EGFP, **p < 0.01; D72A, **p < 0.01; D106A, **p < 0.01; F69L + T70I + D72A, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (d) F69L, T70I, D72A, D106A, F284A, A230F + Q234F, and F69L + T70I + D72A mutations decreased the percentage of branched cilia. EGFP, ***p < 0.001; F69L, **p < 0.01; T70I, *p < 0.05; D72A, ***p < 0.001; D106A, ***p < 0.001; F284A, **p < 0.01; A230F + Q234F, *p < 0.05; F69L + T70I + D72A, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). All groups were compared with the 5-HT6 group, which was transfected with 5-HT6-GFP. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent protein
Fig. 3 5-HT6 mutations regulated ciliary length, cilia branching number, and percentage of neurons with branched cilia. (a) D72A, D106A, and F69L + T70I + D72A mutations influenced ciliary length. These mutations of 5-HT6 restored primary ciliary length increased by overexpression of 5-HT6. 5-HT6 (green) indicated primary cilia. (b) D72A, D106A, and F69L + T70I + D72A mutations restored normal cilia length. EGFP, ***p < 0.001; D72A, **p < 0.01; D106A, **p < 0.01; F69L + T70I + D72A, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). (c) D72A, D106A, and F69L + T70I + D72A mutations influenced the number of ciliary branches. These mutations of 5-HT6 significantly reduced the number of ciliary branches. EGFP, **p < 0.01; D72A, **p < 0.01; D106A, **p < 0.01; F69L + T70I + D72A, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (d) F69L, T70I, D72A, D106A, F284A, A230F + Q234F, and F69L + T70I + D72A mutations decreased the percentage of branched cilia. EGFP, ***p < 0.001; F69L, **p < 0.01; T70I, *p < 0.05; D72A, ***p < 0.001; D106A, ***p < 0.001; F284A, **p < 0.01; A230F + Q234F, *p < 0.05; F69L + T70I + D72A, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). All groups were compared with the 5-HT6 group, which was transfected with 5-HT6-GFP. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent proteinCC BY · PubMed Central
Fig. 4 5-HT6 mutations regulated the locations of ARL13B and AnkG proteins. (a) D72A, D106A, and F69L + T70I + D72A mutations influenced the ciliary location of ARL13B. Overexpression of 5-HT6 delocalized ARL13B in primary cilia. D72A, D106A, and F69L + T70I + D72A mutations of 5-HT6 led to relocation of ARL13B (red) into the cilia. 5-HT6 (green) indicated primary cilia of hippocampal neurons. (b) D72A, D106A, and F69L + T70I + D72A mutations restored the ciliary location of ARL13B. Overexpression of 5-HT6 led to delocalization of ARL13B in primary cilia. EGFP, ***p < 0.001; D72A, *p < 0.05; D106A, *p < 0.05; F69L + T70I + D72A, *p < 0.05 (Kruskal–Wallis test, p < 0.001). (c) AnkG was originally located at the AIS, but it was located at the primary cilia following overexpression of 5-HT6. 5-HT6 mutations did not restore the location of AnkG. EGFP, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). All groups were compared with the 5-HT6 group, which was transfected with 5-HT6-GFP. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent protein
Fig. 4 5-HT6 mutations regulated the locations of ARL13B and AnkG proteins. (a) D72A, D106A, and F69L + T70I + D72A mutations influenced the ciliary location of ARL13B. Overexpression of 5-HT6 delocalized ARL13B in primary cilia. D72A, D106A, and F69L + T70I + D72A mutations of 5-HT6 led to relocation of ARL13B (red) into the cilia. 5-HT6 (green) indicated primary cilia of hippocampal neurons. (b) D72A, D106A, and F69L + T70I + D72A mutations restored the ciliary location of ARL13B. Overexpression of 5-HT6 led to delocalization of ARL13B in primary cilia. EGFP, ***p < 0.001; D72A, *p < 0.05; D106A, *p < 0.05; F69L + T70I + D72A, *p < 0.05 (Kruskal–Wallis test, p < 0.001). (c) AnkG was originally located at the AIS, but it was located at the primary cilia following overexpression of 5-HT6. 5-HT6 mutations did not restore the location of AnkG. EGFP, ***p < 0.001 (Kruskal–Wallis test, p < 0.001). All groups were compared with the 5-HT6 group, which was transfected with 5-HT6-GFP. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent proteinCC BY · PubMed Central
Fig. 5 5-HT6 regulated primary ciliary length through ARL13B. (a) CO-IP showed that 5-HT6 could bind with ARL13B in Hek293T cells. Bidirectional results showed that 5-HT6 and ARL13B interacted. (b) ARL13B restored the length of primary cilia. Cotransfection of ARL13B and 5-HT6 reduced cilia length, which was increased by overexpression of 5-HT6. (c) Ciliary length was shortened by expression of ARL13B. All groups were compared with the 5-HT6 group. Vector, **p < 0.01; ARL13B, **p < 0.01; 5-HT6 + ARL13B, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (d) 5-HT6 had no effect on the total protein level of ARL13B in HEK293T cells. Kruskal–Wallis test, p = 0.85. GAPDH was the internal control. (e) D72A and F69L + T70I + D72A mutations of 5-HT6 influenced the quantity of cAMP (two-way ANOVA: concentration, F 6,12 = 5.45, p < 0.05; treatment, F 2,12 = 9.31, p < 0.01). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, GFP green fluorescent protein
Fig. 5 5-HT6 regulated primary ciliary length through ARL13B. (a) CO-IP showed that 5-HT6 could bind with ARL13B in Hek293T cells. Bidirectional results showed that 5-HT6 and ARL13B interacted. (b) ARL13B restored the length of primary cilia. Cotransfection of ARL13B and 5-HT6 reduced cilia length, which was increased by overexpression of 5-HT6. (c) Ciliary length was shortened by expression of ARL13B. All groups were compared with the 5-HT6 group. Vector, **p < 0.01; ARL13B, **p < 0.01; 5-HT6 + ARL13B, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (d) 5-HT6 had no effect on the total protein level of ARL13B in HEK293T cells. Kruskal–Wallis test, p = 0.85. GAPDH was the internal control. (e) D72A and F69L + T70I + D72A mutations of 5-HT6 influenced the quantity of cAMP (two-way ANOVA: concentration, F 6,12 = 5.45, p < 0.05; treatment, F 2,12 = 9.31, p < 0.01). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, DAPI 4',6-diamidino-2-phenylindole, GFP green fluorescent proteinCC BY · PubMed Central
Fig. 6 5-HT6 regulated axonal length in hippocampal neurons. (a) 5-HT6 regulated axonal length of neurons in WT mice. AnkG (purple), mCherry (red), and DAPI (blue) indicated the axons of hippocampal neurons. (b) 5-HT6 influenced axonal length in WT and APP/PS1 mice. Axonal length in APP/PS1 mice was shorter than that of WT mice. Overexpression of 5-HT6 decreased axonal length. Knocking down 5-HT6 increased axonal length. 5-HT6 versus vector in WT, **p < 0.01; 5-HT6 siRNA versus vector in WT, **p < 0.01; 5-HT6 versus vector in APP/PS1, **p < 0.01; 5-HT6 siRNA versus vector in APP/PS1, **p < 0.01; APP/PS1 versus WT in vector, *p < 0.05 (two-way ANOVA: interaction, F 2,115 = 1.05, p = 0.35; treatment, F 2,115 = 20.22, p < 0.001; gene, F 1,115 = 7.94, p < 0.01) (c) AnkG indicated the AIS. NF186 (red) and AnkG (green) were markers of the AIS. MAP2 (purple) marked neurons. (d) 5-HT6 regulated AIS length. NF186 (purple) indicated the AIS. (e) Overexpression of 5-HT6 increased AIS length. Knocking down 5-HT6 decreased AIS length. 5-HT6, **p < 0.01; 5-HT6 siRNA, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (f) 5-HT6 mutations influenced AIS length. Mutations F69L, T70I, D72A, D106A, A230F, and K262A recovered normal AIS length. EGFP, **p < 0.01; F69L, **p < 0.01; T70I, **p < 0.01; D72A, **p < 0.01; D106A, **p < 0.01; A230F, **p < 0.01; K262A, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (g) Overexpression of 5-HT6 reduced the distance between the AIS and cell body. (h) Overexpression of 5-HT6 decreased the distance between the AIS and cell body. 5-HT6, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (i) 5-HT6 mutations influenced the distance between the AIS and cell body. Mutations D72A and K265A significantly recovered the decreased distance between the AIS and cell body. EGFP, *p < 0.05; D72A, *p < 0.05; K265A, *p < 0.05 (Kruskal–Wallis test, p < 0.01). (j) Overexpression of 5-HT6 increased the percentage of neurons with branched AIS. (k) High expression of 5-HT6 significantly increased the percentage of neurons with branched AIS. 5-HT6, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (l) F69L + T70I + D72A mutation restored the percentage of neurons with branched AIS. EGFP, *p < 0.05; F69L + T70I + D72A, *p < 0.05 (Kruskal–Wallis test, p < 0.01). All groups were compared with the vector group or EGFP group. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, AIS axon initial segment, AnkG ankyrin-3, DAPI 4',6-diamidino-2-phenylindole
Fig. 6 5-HT6 regulated axonal length in hippocampal neurons. (a) 5-HT6 regulated axonal length of neurons in WT mice. AnkG (purple), mCherry (red), and DAPI (blue) indicated the axons of hippocampal neurons. (b) 5-HT6 influenced axonal length in WT and APP/PS1 mice. Axonal length in APP/PS1 mice was shorter than that of WT mice. Overexpression of 5-HT6 decreased axonal length. Knocking down 5-HT6 increased axonal length. 5-HT6 versus vector in WT, **p < 0.01; 5-HT6 siRNA versus vector in WT, **p < 0.01; 5-HT6 versus vector in APP/PS1, **p < 0.01; 5-HT6 siRNA versus vector in APP/PS1, **p < 0.01; APP/PS1 versus WT in vector, *p < 0.05 (two-way ANOVA: interaction, F 2,115 = 1.05, p = 0.35; treatment, F 2,115 = 20.22, p < 0.001; gene, F 1,115 = 7.94, p < 0.01) (c) AnkG indicated the AIS. NF186 (red) and AnkG (green) were markers of the AIS. MAP2 (purple) marked neurons. (d) 5-HT6 regulated AIS length. NF186 (purple) indicated the AIS. (e) Overexpression of 5-HT6 increased AIS length. Knocking down 5-HT6 decreased AIS length. 5-HT6, **p < 0.01; 5-HT6 siRNA, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (f) 5-HT6 mutations influenced AIS length. Mutations F69L, T70I, D72A, D106A, A230F, and K262A recovered normal AIS length. EGFP, **p < 0.01; F69L, **p < 0.01; T70I, **p < 0.01; D72A, **p < 0.01; D106A, **p < 0.01; A230F, **p < 0.01; K262A, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (g) Overexpression of 5-HT6 reduced the distance between the AIS and cell body. (h) Overexpression of 5-HT6 decreased the distance between the AIS and cell body. 5-HT6, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (i) 5-HT6 mutations influenced the distance between the AIS and cell body. Mutations D72A and K265A significantly recovered the decreased distance between the AIS and cell body. EGFP, *p < 0.05; D72A, *p < 0.05; K265A, *p < 0.05 (Kruskal–Wallis test, p < 0.01). (j) Overexpression of 5-HT6 increased the percentage of neurons with branched AIS. (k) High expression of 5-HT6 significantly increased the percentage of neurons with branched AIS. 5-HT6, **p < 0.01 (Kruskal–Wallis test, p < 0.001). (l) F69L + T70I + D72A mutation restored the percentage of neurons with branched AIS. EGFP, *p < 0.05; F69L + T70I + D72A, *p < 0.05 (Kruskal–Wallis test, p < 0.01). All groups were compared with the vector group or EGFP group. Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, AIS axon initial segment, AnkG ankyrin-3, DAPI 4',6-diamidino-2-phenylindoleCC BY · PubMed Central
Fig. 7 SB271046 restored cognitive impairment of APP/PS1 mice in the Morris water maze test. (a) Morphology of the AIS in APP/PS1 and WT mice. AC3 (red) indicated primary cilia. NF186 (purple) indicated the AIS. (b) AIS length was significantly increased in APP/PS1 neurons. Distance between the AIS and cell body was reduced in APP/PS1 neurons. Percentage of branched AIS increased in APP/PS1 neurons. AIS length, **p < 0.01 (Mann–Whitney U test); distance to cell body, *p < 0.05 (Mann–Whitney U test); branched AIS, **p < 0.01 (Mann–Whitney U test). (c) 5-HT6 siRNA reversed AIS morphological changes in APP/PS1 neurons. AIS length, **p < 0.01 (Mann–Whitney U test); distance to cell body, **p < 0.01 (Mann–Whitney U test); branched AIS, **p < 0.01 (Mann–Whitney U test). (d) 5-HT6 antagonist SB271046 had no effect on swimming speed. SB271046 decreased swimming distance and time to reach the platform, and increased time spent in the target quadrant and number of crossings. Compared with WT mice, APP/PS1 mice had obvious cognitive impairment, containing longer swimming distance and time to platform and short time in target quadrant and number of crossings. Swimming speed (two-way ANOVA: interaction, F 1,104 = 0.09, p = 0.77; treatment, F 1,104 = 0.06, p = 0.81; gene, F 1,104 = 1.38, p = 0.24). Swimming distance: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,104 = 0.11, p = 0.74; treatment, F 1,104 = 11.15, p < 0.01; gene, F 1,104 = 16.99, p < 0.001). Time to platform (three-way ANOVA: day, F 5,536 = 118.8, p < 0.001; treatment, F 1,536 = 17.62, p < 0.001; gene, F 1,536 = 29.06, p < 0.001; day × treatment, F 5,536 = 1.08, p = 0.37; day × gene, F 5,536 = 1.04, p = 0.39; treatment × gene, F 1,536 = 0.2, p = 0.65; day × treatment × gene, F 5,536 = 0.33, p = 0.9). Time in target quadrant: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,101 = 0.02, p = 0.88; treatment, F 1,101 = 9.64, p < 0.01; gene, F 1,101 = 9.88, p < 0.01). Crossing times: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, **p < 0.01; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,104 = 0.02, p = 0.88; treatment, F 1,104 = 9.76, p < 0.01; gene, F 1,104 = 10.47, p < 0.01). (e) SB271046 decreased cilia length after water maze of 7 days in vivo. (f) SB271046 restored the longer cilia of APP/PS1 mice. Vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,268 = 0.05, p = 0.82; treatment, F 1,268 = 9.25, p < 0.01; gene, F 1,268 = 15.49, p < 0.001). (g) SB271046 recovered AIS morphology in vivo. AnkG indicated AIS of neuron. Arrows indicate AIS. Calbindin indicated neuron. (h) SB271046 decreased AIS length, increased distance from AIS to cell body, and deceased percentage of branched AIS of neuron. AIS length: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, ***p < 0.001; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,223 = 5.37, p < 0.05; treatment, F 1,223 = 23.45, p < 0.001; gene, F 1,223 = 4.91, p < 0.05). Distance to cell body: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,222 = 0.86, p = 0.36; treatment, F 1,222 = 12.15, p < 0.001; gene, F 1,222 = 4.96, p < 0.05). Branched AIS: vehicle versus SB271046 in WT, p = 0.79; vehicle versus SB271046 in APP/PS1, ***p < 0.001; WT versus APP/PS1 in vehicle, ***p < 0.001 (two-way ANOVA: interaction, F 1,8 = 87.61, p < 0.001; treatment, F 1,8 = 95.26, p < 0.001; gene, F 1,8 = 94.72, p < 0.001). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, AIS axon initial segment, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent protein
Fig. 7 SB271046 restored cognitive impairment of APP/PS1 mice in the Morris water maze test. (a) Morphology of the AIS in APP/PS1 and WT mice. AC3 (red) indicated primary cilia. NF186 (purple) indicated the AIS. (b) AIS length was significantly increased in APP/PS1 neurons. Distance between the AIS and cell body was reduced in APP/PS1 neurons. Percentage of branched AIS increased in APP/PS1 neurons. AIS length, **p < 0.01 (Mann–Whitney U test); distance to cell body, *p < 0.05 (Mann–Whitney U test); branched AIS, **p < 0.01 (Mann–Whitney U test). (c) 5-HT6 siRNA reversed AIS morphological changes in APP/PS1 neurons. AIS length, **p < 0.01 (Mann–Whitney U test); distance to cell body, **p < 0.01 (Mann–Whitney U test); branched AIS, **p < 0.01 (Mann–Whitney U test). (d) 5-HT6 antagonist SB271046 had no effect on swimming speed. SB271046 decreased swimming distance and time to reach the platform, and increased time spent in the target quadrant and number of crossings. Compared with WT mice, APP/PS1 mice had obvious cognitive impairment, containing longer swimming distance and time to platform and short time in target quadrant and number of crossings. Swimming speed (two-way ANOVA: interaction, F 1,104 = 0.09, p = 0.77; treatment, F 1,104 = 0.06, p = 0.81; gene, F 1,104 = 1.38, p = 0.24). Swimming distance: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,104 = 0.11, p = 0.74; treatment, F 1,104 = 11.15, p < 0.01; gene, F 1,104 = 16.99, p < 0.001). Time to platform (three-way ANOVA: day, F 5,536 = 118.8, p < 0.001; treatment, F 1,536 = 17.62, p < 0.001; gene, F 1,536 = 29.06, p < 0.001; day × treatment, F 5,536 = 1.08, p = 0.37; day × gene, F 5,536 = 1.04, p = 0.39; treatment × gene, F 1,536 = 0.2, p = 0.65; day × treatment × gene, F 5,536 = 0.33, p = 0.9). Time in target quadrant: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,101 = 0.02, p = 0.88; treatment, F 1,101 = 9.64, p < 0.01; gene, F 1,101 = 9.88, p < 0.01). Crossing times: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, **p < 0.01; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,104 = 0.02, p = 0.88; treatment, F 1,104 = 9.76, p < 0.01; gene, F 1,104 = 10.47, p < 0.01). (e) SB271046 decreased cilia length after water maze of 7 days in vivo. (f) SB271046 restored the longer cilia of APP/PS1 mice. Vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,268 = 0.05, p = 0.82; treatment, F 1,268 = 9.25, p < 0.01; gene, F 1,268 = 15.49, p < 0.001). (g) SB271046 recovered AIS morphology in vivo. AnkG indicated AIS of neuron. Arrows indicate AIS. Calbindin indicated neuron. (h) SB271046 decreased AIS length, increased distance from AIS to cell body, and deceased percentage of branched AIS of neuron. AIS length: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, ***p < 0.001; WT versus APP/PS1 in vehicle, **p < 0.01 (two-way ANOVA: interaction, F 1,223 = 5.37, p < 0.05; treatment, F 1,223 = 23.45, p < 0.001; gene, F 1,223 = 4.91, p < 0.05). Distance to cell body: vehicle versus SB271046 in WT, *p < 0.05; vehicle versus SB271046 in APP/PS1, *p < 0.05; WT versus APP/PS1 in vehicle, *p < 0.05 (two-way ANOVA: interaction, F 1,222 = 0.86, p = 0.36; treatment, F 1,222 = 12.15, p < 0.001; gene, F 1,222 = 4.96, p < 0.05). Branched AIS: vehicle versus SB271046 in WT, p = 0.79; vehicle versus SB271046 in APP/PS1, ***p < 0.001; WT versus APP/PS1 in vehicle, ***p < 0.001 (two-way ANOVA: interaction, F 1,8 = 87.61, p < 0.001; treatment, F 1,8 = 95.26, p < 0.001; gene, F 1,8 = 94.72, p < 0.001). Scale bars, 10 μm. All data presented as mean ± SEM (≥3 independent experiments). 5-HT6, serotonin 6 receptor, AIS axon initial segment, DAPI 4',6-diamidino-2-phenylindole, EGFP enhanced green fluorescent proteinCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 122

Metadata

Authors
Hu, L., Wang, B., & Zhang, Y.
Affiliations
Peking University (CN)
Corresponding author
Zhang, Yan
Venue
Alzheimer's Research & Therapy
Published
2017-09-20
Volume
9
Issue
1
Pages
76-76
ISSN
1758-9193 (ISSN-L)
OpenAlex
W2756156581
Cited by
98
References
37
Citations by year
2026: 5 · 2025: 14 · 2024: 10 · 2023: 11 · 2022: 17 · 2021: 14 · 2020: 11 · 2019: 12 · 2018: 4
FWCI
5.47
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Alzheimer s Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NSFC Fund for Distinguished Young Scholars (81425009)
  • NSFC major research grant (31630028, 91632305)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
serotonin 5-HT6 receptor, Alzheimer's disease, primary cilia, axon initial segment, hippocampal neurons, APP/PS1 mice, cognitive impairment, ARL13B, axon length, cilia length
MeSH terms
Alzheimer Disease, Animals, Animals, Newborn, Cells, Cultured, Cilia, Cognition Disorders, Disease Models, Animal, Gene Expression Regulation, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Receptors, Serotonin, Serotonin, Amyloid beta-Protein Precursor, Maze Learning, ADP-Ribosylation Factors, RNA, Small Interfering, Mice, Presenilin-1, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function. https://app.cochat.ai/papers/10.1186/s13195-017-0304-4
The paper
Hu, L., Wang, B., & Zhang, Y. (2017). Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-017-0304-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.